Cargando…
Assessment of Cardiotoxicity after a Single Dose of Combretastatin A4-Phosphate in Dogs Using Two-Dimensional Speckle-Tracking Echocardiography
SIMPLE SUMMARY: Combretastatin A4-phosphate is a chemotherapeutic drug which has been evaluated for treatment of solid canine tumors. Previous studies reported cardiotoxic effects based on changes in cardiac troponin I measurements, blood pressure, and electrocardiography. We evaluated the cardiotox...
Autores principales: | Mampaey, Gitte, Hellemans, Arnaut, de Rooster, Hilde, Schipper, Tom, Abma, Eline, Broeckx, Bart J. G., Daminet, Sylvie, Smets, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658292/ https://www.ncbi.nlm.nih.gov/pubmed/36359129 http://dx.doi.org/10.3390/ani12213005 |
Ejemplares similares
-
Reference interval, longitudinal variability and reliability of activated clotting time in healthy dogs using a point‐of‐care analyser
por: Hellemans, Arnaut, et al.
Publicado: (2023) -
Pretreatment with tadalafil attenuates cardiotoxicity induced by
combretastatin A4 disodium phosphate in rats
por: Nagashima, Yoshiyasu, et al.
Publicado: (2023) -
Diagnosis and management of arrhythmias in dogs: A cross‐sectional online survey among Flemish veterinary practitioners
por: Hellemans, Arnaut, et al.
Publicado: (2022) -
Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients
por: Abma, Eline, et al.
Publicado: (2019) -
Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats
por: Roche‐Catholy, Marine, et al.
Publicado: (2022)